Stockreport

ArriVent Appoints John Hohneker, M.D., to its Board of Directors

ArriVent BioPharma, Inc.  (AVBP) 
PDF NEWTON SQUARE, Pa., May 16, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative [Read more]